RFID: FDA Anti-Counterfeit Drug Initiative Workshop

The FDA Anti-Counterfeit Drug Initiative Public Workshop and Vendor Display is scheduled for February 8-9, 2006, in Bethesda, Maryland.

According to the DEPARTMENT OF HEALTH AND HUMAN SERVICES Docket No. 2005N–0510 (Anti-Counterfeit Drug Initiative Workshop and Vendor Display), the three objectives of the meeting are:

To identify incentives for widespread adoption of radio-frequency identification (RFID), as well as obstacles to the adoption of RFID across the U.S. drug supply chain and possible solutions to those obstacles.

To solicit comment on the implementation of the pedigree requirements of the
Prescription Drug Marketing Act (PDMA) and the use of an electronic pedigree
e-pedigree).

To learn the state of technology development related to electronic track and trace and e-pedigree technology solutions.

Interested individuals, organizations, and vendors may register on-line to attend the workshop, display their products or deliver a presentation to the FDA's Counterfeit Drug Task Force.

Understand that whether or not to proceed with electronic pedigree (e.g., RFID) is not open for discussion. The FDA is moving forward with electronic track-and-trace, regardless of how you or I or anyone else feels about it.

Sally Bacchetta - Freelance Writer
Freelance Writer
RFID